GUB014295
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GUB014295, covering 2026-01-15 to 2026-01-15. Get the full timeline:
Most recent: Clinical Trial Update: A Two-Part First-In-Human Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GUB014295 [Phase 1]